Login
  • Bookmark
  • PDF
  • Share
  • CaseIQ

HOVEY v. ASTRUE

United States District Court, M.D. Alabama, Southern Division.
Dec 8, 2010
Important Paras
Please sign up to view Important Paras.
MEMORANDUM AND ORDER

JOHN JONES III, District Judge

THE BACKGROUND OF THIS ORDER IS AS FOLLOWS:

Pending before the Court is a Motion to Dismiss (Doc. 34) filed by Third-Party Defendant ColorMatrix Corporation. For the reasons that follow, the motion shall be denied.

I. FACTUAL BACKGROUND and PROCEDURAL HISTORY

Plaintiff Tulpehocken Spring Water, Inc. ("TSW" or "Plaintiff TSW") a corporation with its principal place of business in Pennsylvania, is engaged in the business of bottling, selling, and delivering bottled spring water products. (Doc. 1, Ex. 1 ¶¶ 1, 3). Plaintiff TSW purchases bottles and closures from third-party manufacturers. ( Id. ¶ 4). Defendant/Third-Party Plaintiff Obrist Americas, Inc., t/d/b/a Global Closure Systems ("Obrist" or "Third-Party Plaintiff") is a Delaware corporation, with its principal place of business in Virginia, and is engaged in manufacturing and selling a variety of plastic and metallic closures, caps, and lids. ( Id. ¶¶ 2, 5). During the relevant period, Third-Party Defendant ColorMatrix Corporation ("Colormatrix" or "Third-Party Defendant") was an Ohio corporation, with its principal place of business in the same state, engaged in the sale of tints or colorants used to color bottle caps. (Doc. 26 ¶¶ 2, 8).

Since September 12, 2006, Plaintiff TSW has purchased plastic bottle caps manufactured by Obrist through a third-party broker, Frost Packaging, Inc., without any complaints or issues. (Doc. 1, Ex. 1 ¶ 6). On or about April 18, 2008, Plaintiff placed an order for five (5) million flat-top, screw on style plastic bottle caps from Obrist. ( Id. ¶ 7). According to Plaintiff, Obrist manufactured the requested order but sold the caps to a third party requiring Obrist to "rush order" Plaintiff's requested order within three (3) days. ( Id. ¶¶ 8-9). The alleged "rush order" of caps were shipped to Plaintiff on or about June 10, 2008, which Plaintiff used in the production of its bottled water products produced during June 2008. ( Id. ¶ 13).

Plaintiff TSW shipped its bottled spring water to several customers on or about July 21, 2008. ( Id. ¶ 14). Thereafter, Plaintiff alleges it received numerous customer complaints claiming that the water had a "bad taste." ( Id. ¶¶ 15-18). Subsequently, TSW conducted various tests on the water and plastic bottles, the results of which failed to account for the bad water taste. ( Id. ¶¶ 19-20). Based on these results, Plaintiff concluded that Obrist's flat-top screw on style bottle caps were the underlying cause for the water's bad taste. ( Id. ¶¶ 21-22).

On October 13, 2009, Plaintiff TSW filed a complaint in the Court of Common Pleas, Northumberland County, against Defendant/Third-Party Plaintiff Obrist. (Doc. 1, Ex. 1). Plaintiff's complaint alleged violations of Pennsylvania law including breach of the implied warranty of merchantability in Count I, and breach of the implied warranty of fitness for a particular purpose in Count II. ( See id.). In particular, Plaintiff alleges that Obrist sold it defective caps which failed to properly seal the bottle and protect its contents from impurities that caused the water's flavor to be tainted. ( Id. ¶ 31). Obrist subsequently removed the lawsuit to federal court based on diversity jurisdiction on November 6, 2009. (Doc. 1). Obrist filed an answer to the complaint on November 10, 2009. (Doc. 3).

On June 1, 2010, Obrist filed a Motion to Extend the Time to Amend Pleadings and Join Third Parties, alleging that pending scientific analyses suggested that another party, Colormatrix, may be responsible for the damages Plaintiffs alleged. ( See Doc. 22). On the same day, the Court granted Obrist's motion for extension of time to join. (Doc. 23). On June 30, 2010, Obrist sought leave of the Court to file a third-party complaint against Colormatrix, (Doc. 24), which was granted the same day. (Doc. 29). Obrist filed a third-party complaint pursuant to Rule 14 of the Federal Rules of Civil Procedure asserting derivative liability against ColorMatrix based on theories of indemnification and contribution. ( See Doc 26). Obrist's third-party claim focuses on ColorMatrix, the company that supplied the tints and colorants used to color the bottle caps, as well as the allegedly defective bottle caps purchased by TSW. According to Obrist, to the extent the bottle caps are found to have been defective, any defects resulted solely from the tints or colorants supplied by ColorMatrix and are not the result of any action on Obrist's behalf. ( See id.).

Federal Rule of Civil Procedure 14(a)(1) provides "[a] defending party may, as third-party plaintiff, serve a summons and complaint on a nonparty who is or may be liable to it for all or part of the claim against it."

In response, ColorMatrix filed the instant motion to dismiss, and brief in support thereof, (Docs. 34, 35), pursuant to Federal Rule of Civil Procedure 12(b)(1) alleging that the third-party complaint should be dismissed without prejudice on grounds that the claims therein are not ripe for determination. Specifically, ColorMatrix contends that the claims are dependent upon contingent future events that might not occur as anticipated, or may not occur at all, and that the third-party complaint fails to allege sufficient facts to support either a claim for contribution or indemnification. ( See Doc. 34, 35). Obrist filed an answer and brief in opposition to the motion on August 27, 2010. (Docs. 37, 38). At present, ColorMatrix has neglected to file a reply brief and the time for filing the same has expired. Accordingly, the motion is ripe for disposition.

II. STANDARD OF REVIEW

When considering a motion to dismiss under Rule 12(b)(1), a court must distinguish between facial and factual challenges to its subject matter jurisdiction. See Mortensen v. First Fed. Sav. Loan Ass'n, 549 F.2d 884, 891 (3d Cir. 1977). A facial attack challenges whether the plaintiff has properly pled jurisdiction. Id. "In reviewing a facial attack, the court must only consider the allegations of the complaint and documents referenced therein and attached thereto, in the light most favorable to the plaintiff." Gould Elecs., Inc. v. United States, 220 F.3d 169, 176 (3d Cir. 2000) (citing Mortensen, 549 F.2d at 891). A factual attack, in contrast, challenges jurisdiction based on facts apart from the pleadings. Mortensen, 549 F.2d at 891. "When a defendant attacks subject matter jurisdiction `in fact,' . . . the Court is free to weigh the evidence and satisfy itself whether it has power to hear the case. In such a situation, `no presumptive truthfulness attaches to plaintiff's allegations, and the existence of disputed material facts will not preclude the trial court from evaluating for itself the merits of jurisdictional claims.'" Carpet Group Int'l v. Oriental Rug Importers Ass'n, 227 F.3d 62, 69 (3d Cir. 2000) (quoting Mortensen, 549 F.2d at 891).

In the case sub judice, ColorMatrix lodges a factual challenge against subject matter jurisdiction. Thus, the Court is free to weigh the evidence and determine whether it has the power to hear the case without accepting as true all well-pled allegations contained in Obrist's third-party complaint.

III. DISCUSSION

ColorMatrix argues that Obrist's third-party complaint must be dismissed without prejudice on grounds that neither the indemnification claim nor the contribution claim are ripe for determination. They contend that dismissal is appropriate because Obrist's claims are premised solely upon the possibility that Obrist may be found liable to TSW, and that a link may be established between ColorMatrix's tints and colorants and the bad tasting water of which TSW complains. (Doc. 35 at 3). According to ColorMatrix, the claims asserted in the third-party complaint are unripe because they are dependent upon contingent future events that might not occur as anticipated, or in the alternative, may not occur at all. ( See id.).

Therefore, ColorMatrix contends, because the claims are unripe this Court lacks subject matter jurisdiction over Obrist's third-party complaint. ColorMatrix asserts that even if the Court concludes that subject matter jurisdiction is proper, the Court may still dismiss Obrist's third-party complaint on ripeness grounds. (Doc. 35 at 4). Regardless, ColorMatrix maintains, Obrist will either have to "prove that it discharged the liability of ColorMatrix to TSW," or, alternatively, prove "that Obrist was only secondarily liable to TSW." ( Id. at 4).

The function of the ripeness doctrine is to prevent federal courts from entangling themselves in abstract disagreements by allowing them to avoid premature adjudication. See Abbott Labs. v. Gardner, 387 U.S. 136 (1967). The Court in Abbott Laboratories established a two-prong test for determining ripeness which includes (1) the fitness of the issues for judicial decision, and (2) the hardship to the parties of withholding court consideration. Id. at 149. The ripeness doctrine requires that the subject challenge grow out of a "real, substantial controversy between the parties" involving a "dispute definite and concrete." Peachlum v. City of York, 333 F.3d 429, 434 (3d Cir. 2003) (quoting Babbitt v. United Farm Workers Nat'l Union, 442 U.S. 289, 298 (1979)).

Finally, although not specifically styled as such, ColorMatrix raises a 12(b)(6) argument in opposition to Obrist's third-party claim. ColorMatrix asserts that Obrist fails, under Federal Rule of Civil Procedure 8(a)(2), to "include a short and plain statement of the claim showing that the pleader is entitled to relief." ( Id. at 5). They maintain that Obrist's complaint, viewed in "light of the totality of the record before the Court," is insufficient to demonstrate how ColorMatrix's product caused TSW's alleged loss. ( Id.). However, ColorMatrix does not seek dismissal of the third-party complaint with prejudice because it acknowledges that at some point in the future Obrist may have "factual and legal support" for its contribution and indemnity claims. ( Id. at 6). Rather, they seek dismissal of the third-party complaint at present to avoid "incur[ring] the expense associated with defending a contingent and apparently scientifically unsupported claim." ( Id. at 6).

In response, Obrist argues that ColorMatrix's motion is without merit in that it seeks to circumvent the benefits of judicial economy inherent in third-party practice. (Doc. 39 at 2). Obrist contends that adoption of ColorMatrix's position, that Obrist first admit liability prior to bringing ColorMatrix into the suit as a third party, is patently wrong. ( See id. (citing Yarnell v. Roberts, 66 F.R.D. 417, 423 (E.D. Pa. 1975) ("The theory of Rule 8 is that a defendant's pleading should apprise the plaintiff of the allegations in the complaint that stand admitted and will not be in issue at trial and those that are contested and will require proof to be established to enable plaintiff to prevail."))). Obrist asserts that even under the post- Iqbal pleading standards a plaintiff is not required to plead its evidence, but instead is only required to "aver sufficient factual allegations which nudge its claim across the line from conceivable to plausible." ( See Doc. 39 at 4 (citing Onconome, Inc. v. Univ. of Pittsburgh, 2010 WL 1133425, at *2 (W.D. Pa. 2010)).

As to ColorMatrix's ripeness argument, Obrist argues that ripeness is only concerned with whether a case or controversy is properly before the court. ( See Doc. 39 at 2 (citing Nextel Commc'ns. of the Mid-Atlantic, Inc. v. City of Margate, 305 F.3d 188, 192 (3d Cir. 2002))). Obrist argues that its claims, far from being speculative or contingent, are based upon concrete, compensable loses articulated in TSW's complaint and therefore a real live case or controversy is presently before the Court. (Doc. 39 at 3). Additionally, Obrist cites Armstrong World Industries Incorporated ex rel. Wolfson v. Adams for the proposition that "a plaintiff need not suffer a completed harm to establish adversity of interest between the parties." 961 F.2d 405, 412 (3d Cir. 1992). Obrist also highlights our colleague, Judge Sylvia Rambo, who noted:

a third party complaint may not set forth a claim of the third party defendant's liability to the plaintiff. It must set forth a claim of secondary liability such that, if the third party plaintiff is found liable, the third party defendant will be liable to him/her under a theory of indemnification, contribution, or some other theory of derivative liability recognized by the relevant substantive law. . . . A theory that another party is the correct defendant is not appropriate for a third party complaint.
Toberman v. Copas, 800 F.Supp. 1239, 1242 (M.D. Pa. 1992).

In sum, Obrist submits that its third-party complaint presents precisely the elements Rule 14 demands, a claim for secondary liability against ColorMatrix on the basis of indemnification or contribution in the event it is found liable to TSW. We agree with Obrist and find ColorMatrix's ripeness argument and subject-matter jurisdiction challenge to be without merit.

The Third Circuit, in Hatco Corporation v. W.R. Grace Company, remarked in a footnote that "[a]lthough a claim for indemnity does not arise until the prime obligation to pay has been established, some third-party actions may be commenced in the interest of judicial economy before they are technically ripe." 59 F.3d 400, 406 (3d Cir. 1995). Here, despite the fact that Obrist's liability to TSW, if any, has yet to be determined, we find that commencement of a third-party claim against ColorMatrix, which may arguably raise ripeness issues, is appropriate at this stage of the litigation and adequately supports our goal of judicial economy. In Hanhauser v. United States another of our colleagues, Judge Richard Conaboy, noted that a third-party complaint is proper pursuant to Rule 14:

only if the third party's liability is in some way dependent on an outcome of the main claim or when the third party is secondarily liable to the Defendant. The secondary or derivative liability notion is central and it is irrelevant whether the basis of the Third-Party claim is indemnity, subrogation, contribution, express or implied warranty or some other theory.
85 F.R.D. 89, 90 (M.D. Pa. 1979) (emphasis added) (citing 6 CHARLES ALAN WRIGHT ARTHUR MILLER, FEDERAL PRACTICE AND PROCEDURE § 1446 at 246 (1971)).

In the case sub judice, we find that Obrist's third-party complaint sufficiently alleges that ColorMatrix's liability to Obrist is contingent upon the outcome of TSW's initial claim against Obrist. In Count I of the third-party complaint, Obrist seeks indemnification "[i]f it is determined that Obrist is in any way liable to Tulpehocken, or any other party" and that the Court "name ColorMatrix liable for all sums that may be adjudged against Obrist in favor of [TSW]. . . ." (Doc. 26 at 4). Similarly, in Count II, Obrist seeks contribution "[i]f it is determined that Obrist is in any way liable to Tulpehocken, or any other party" and that "the Court enter judgment in favor of Obrist and against ColorMatrix for all sums that may be adjudged against Obrist in favor of [Plaintiff]. . . ." ( Id. at 6). Thus, we find that Obrist's third-party complaint properly alleges contingent liability on behalf of ColorMatrix to the extent Obrist is found liable to TSW. Accordingly, Obrist's claim for indemnity or contribution is specifically "dependent on an outcome of the main claim" and is therefore proper under Rule 14 notwithstanding ColorMatrix's ripeness concerns. See Hanhauser, 85 F.R.D. at 90.

Furthermore, in finding that Obrist's third-party complaint has been properly pled pursuant to Rule 14, we find Judge Rambo's analysis in Toberman v. Copas to be particularly helpful. See Toberman, 800 F.Supp. 1239. In that case, in considering whether a third-party complaint was proper under Rule 14, the court concluded that the third-party claim "of sole and direct liability to Plaintiffs [did] not comprise a proper third party claim under Rule 14." Toberman, 800 F.Supp. at 1242. In contrast to the third-party complaint in Toberman, which apparently alleged that the third-party defendant was solely and directly liable to the original plaintiff, Obrist's third-party complaint does not allege that ColorMatrix is solely or directly liable to TSW. Rather, as noted above, Obrist alleges in both counts that "[i]f it is determined that Obrist is in any way liable to [TSW], or any other party," Obrist is entitled to indemnification or contribution to the extent of its liability stemming from ColorMatrix's negligent manufacture of the tints or colorants purchased by Obrist. (Doc. 26 at 4-5).

Based on a plain reading of Obrist's third-party claim, it does not appear that Obrist seeks to impose "sole and direct liability" upon ColorMatrix, or suggest that ColorMatrix is essentially the "correct" defendant with regard to TSW's original complaint. See Toberman, 800 F.Supp. at 1242. Instead, Obrist seeks indemnification or contribution from ColorMatrix to the extent, if at all, it is found liable to TSW. See Stiber v. United States, 60 F.R.D. 668, 669 (E.D. Pa. 1973) ("Under Rule 14(a), the allegations of the third-party complaint need not show that the recovery is a certainty and the complaint should be allowed to stand if, under some construction of the facts, which might be adduced at trial, recovery would be possible. Rule 14 is, therefore, clearly not limited to situations where the third-party defendant will automatically be liable to the defendant for all or part of the plaintiff's claim."). Here, Obrist has properly pled sufficient factual allegations that could yield a recovery from ColorMatrix in the event Obrist is ultimately found liable to TSW. Therefore, we find that Obrist has filed a proper third-party complaint under Rule 14 sufficient to survive ColorMatrix's motion to dismiss.

Additionally, we find that jurisdiction over this claim is proper pursuant to this Court's supplemental jurisdiction under 28 U.S.C. § 1367(b). As the court noted in Pride Mobility Products Corporation v. Dylewski, "§ 1367(b) reflects Congress' intent to prevent original plaintiffs — but not defendants or third parties — from circumventing the requirements of diversity." 2009 U.S. Dist. LEXIS 5530, at *21 (M.D. Pa. Jan. 27, 2009) (emphasis in original) (citing Viacom Int'l, Inc. v. Kearney, 212 F.3d 721, 726-27 (2d Cir. 2000)). Here, the instant claim was initiated by third-party plaintiff Obrist and therefore the prohibition in 28 U.S.C. § 1367(b) regarding claims brought by "plaintiffs against persons made parties under Rule 14 . . ." is inapplicable. See Westra Constr., Inc. v. United States Fid. Guar. Co., 546 F.Supp.2d 194, 199 (M.D. Pa. 2008) (noting that the "evident purpose of § 1367(b) is to prevent a two-step evasion of the requirement of complete diversity of citizenship by a person who, being of the same citizenship as the defendant, waits to sue until a diverse party with which it is aligned sues the defendant, and then joins the suit as an intervening plaintiff."). Therefore, we find that supplemental jurisdiction is proper over the instant matter. Accordingly, we shall deny the third-party defendant's motion to dismiss.

28 U.S.C. § 1367(b) provides "[i]n any civil action of which the district courts have original jurisdiction founded solely on section 1332 of this title, the district courts shall not have supplemental jurisdiction under subsection (a) over claims by plaintiffs against persons made parties under Rule 14, 19, 20, or 24 of the Federal Rules of Civil Procedure, or over claims by persons proposed to be joined as plaintiffs under Rule 19 of such rules, or seeking to intervene as plaintiffs under Rule 24 of such rules, when exercising supplemental jurisdiction over such claims would be inconsistent with the jurisdictional requirement of section 1332. (emphasis added).

NOW, THEREFORE, IT IS HEREBY ORDERED THAT:

1. Third-Party Defendant ColorMatrix's Motion to Dismiss the Third Party Complaint (Doc. 34) is DENIED.

tapering course of Prednisone." He had finished the steroid course by the time of his December 15, 2000 follow-up with Dr. Prophet and was, by then, "symptom-free[.]" Dr. Prophet then noted that plaintiff was "stable overall and doing rather well." (R. 503). At a follow-up appointment with Dr. Sherrer on January 15, 2001 — plaintiff's alleged onset date — plaintiff stated that he was "doing well" as to his asthma, heart disease and hypertension. Dr. Sherrer wrote that plaintiff was "having no chest pain, cardiac symptoms, respiratory distress, or other abnormalities except for raised skin lesion to the left forearm." (R. 574). On March 20, 2001, Dr. Sherrer treated plaintiff for sinus congestion, headache and postnasal drip. (R. 572).

This lesion was diagnosed as squamous cell carcinoma on January 30, 2001; plaintiff had a skin graft sometime between mid-February and mid-March. (R. 59, 572-73).

At plaintiff's six-month follow-up appointment on June 26, 2001, Dr. Prophet indicated "[the plaintiff] had an up and down six months with several mild-to-moderate exacerbations of the asthma, at least one of which required an emergency room visit in April." (R. 502). Dr. Prophet wrote, "The biggest stress however has been the deteriorating health of his mother who continues to live up in Barbour County so [plaintiff] is driving up there frequently, spending the night, helping with her and plus doing his full time job here." Dr. Prophet concluded that the plaintiff was fairly stable overall, and stated, "As I discussed with him I suspect the stress of his lifestyle is causing some aggravation of his asthma. The sinus problem [mild sinus drainage] may be a contributing factor as well." (R. 502). The following day, plaintiff returned to Dr. Sherrer for follow-up. Dr. Sherrer wrote, "States that he has had some allergy symptoms and some sinus drainage over the past several weeks. The patient has had no other complaints. States that he is doing well and has followed up with both of his consultants specifically Cardiology and Pulmonology and has been given clean bills of health." (R. 572). On October 22, 2001, plaintiff sought treatment from Dr. Sherrer for increased wheezing and shortness of breath over the past one to two weeks, which he reported initially began as sinus congestion and drainage. Plaintiff received a shot of Decadron and Depomedrol and used an Albuterol nebulizer twice in the office. The "[w]heezing essentially resolved post treatment." Plaintiff returned the following day as directed, and said that he was feeling much better. He denied "any shortness of breath or breathing difficulty or wheezing." (R. 569-70).

Plaintiff returned to Dr. Prophet for his six-month follow-up two months later, on December 27, 2001. Dr. Prophet noted that plaintiff was "doing reasonably well but has had a little more trouble this fall than usual with the need for three rounds or so of Prednisone. . . . He is under a lot of stress with dealing with his mother's health problems along with the usual flurry of business activities and this may be contributing somewhat to his problems." Dr. Prophet concluded that plaintiff was "having some instability in his asthma." He prescribed a prolonged Prednisone taper, noting that "if that were to fail to get it under control, we might consider adding a leukotriene inhibitor. Stress reduction would probably help as well." (R. 501). At a routine check-up with Dr. Sherrer on January 10, 2002, plaintiff stated that he "feels well" in general. He denied any shortness of breath or breathing problems, "other than his chronic pulmonary status." (R. 568). A week later, on January 17, 2002, Dr. Prophet noted that plaintiff was "much improved" and "doing well." (R. 500). In February 2002, while he was still tapering his Prednisone, he "got around some heavy Clorox fumes which caused severe bronchospasm," and he "bumped his Prednisone back up to 40 mg and has tapered it back down to [10 mg]." Dr. Prophet noted, "There is also some stress with Valentine's Day activities which may have aggravated his breathing as well." By February 21, 2002, he was "breathing fairly well" and "feeling well," and he was "having no nocturnal dyspnea or cough." (R. 499).

On March 21, 2002, Dr. Prophet noted that plaintiff was then "stable" but had been hospitalized for a few days in late February and early March "with exacerbation of his asthma which did not respond to higher dose Prednisone or treatment at the emergency room." By the time of his office visit, he was "breathing quite well but still note[d] a generalized sense of fatigue." (R. 498). On April 10, 2002, plaintiff told Dr. Sherrer that he was "doing well and is having no complaints" and "no respiratory distress." (R. 567). At a follow-up with Dr. Prophet eight days later, plaintiff was "feeling well, having regained most of his endurance[,] and reported "no cough, sputum, wheezing, chest pain or other problems off of Prednisone." Dr. Prophet noted that he "is stable and doing quite well." (R. 497). On July 22, 2002, plaintiff reported to Dr. Sherrer that he "feels well" and he denied any chest pain, palpitations, shortness of breath or breathing difficulties. (R. 566). On July 31, 2002, plaintiff had some "sinus stuffiness and mild sinus drainage" which Dr. Prophet wanted to treat symptomatically; he planned to obtain a CT of the sinuses if plaintiff's symptoms persisted. Dr. Prophet noted that plaintiff was "generally stable," and that he had done "reasonably well with his asthma" with a "little flare-up earlier this month" which had resolved with a burst of Prednisone. (R. 496).

Plaintiff reported some new skin lesions for which Dr. Sherrer referred him to Dr. Pynes, a dermatologist. (R. 566).

Plaintiff returned for evaluation on August 19, 2002. Dr. Prophet wrote:

[Plaintiff] comes in after having been seen in the emergency room last week with an exacerbation of his asthma. This began about eight days ago after eating a lot of snow crab legs on a Saturday evening. [He] has noted a little bit of wheezing when he ate shrimp and has stopped eating shrimp but unfortunately has continued to eat the snow crab. He called us last Monday but continued to deteriorate and finally went to the emergency room where he received a tapered course of steroids which he finished two days ago and now is breathing quite well. This exacerbation is not associated with any sinus problems. . . . [He] appears to have recovered from the flare of asthma. I suspect this is due to an iodine sensitivity and not due to sinus problems.

(R. 495). Two months later, in October 2002, plaintiff was hospitalized "with an exacerbation of his asthma provoked in part by his sinuses." (R. 494). He developed significant hyperglycemia in the hospital due to the steroids used to treat his asthma. (R. 494, 550-51). Dr. Morriss, plaintiff's primary care physician at Southern Clinic, saw the plaintiff on October 21, 2002, for a post-hospitalization follow-up. Dr. Morriss wrote, "[Plaintiff] is doing much better with his breathing and is followed by Dr. Dale Pro[phet] for this problem. He has, otherwise, done fairly well." Dr. Morriss noted that the plaintiff had "Type II diabetes mellitus, recently exacerbated by corticosteriods." (R. 550-51). Plaintiff saw Dr. Prophet the following day. Dr. Prophet noted that plaintiff was off of the Prednisone and his blood sugar was under good control with diet and Amaryl 1 mg daily. Dr. Prophet wrote that plaintiff's "breathing is doing quite well" and that he was "much improved." (R. 494).

Plaintiff did "quite well" for the next three months, requiring no interventions until he experienced some increased wheezing caused by the intense cold weather in mid-January 2003. He told Dr. Prophet on January 23, 2003 that his blood sugars were "doing well." Dr. Prophet prescribed a Prednisone taper to get plaintiff's increased bronchospasm under control. (R. 493). Plaintiff "had some problems off and on through the spring with his asthma," requiring a couple of rounds of Prednisone. In late April, he told Dr. Prophet that he recovers quickly but relapses when he stops the Prednisone, and that his total cholesterol and blood sugar levels had done well. Dr. Prophet wrote, "[Plaintiff] has suboptimally controlled asthma. I think we need to resume empiric antibiotics for probable sinus disease, as well as a little bit of low dose Prednisone. (R. 492). A month later, Dr. Prophet noted that plaintiff was "doing fairly well but still having some nocturnal symptoms." He noted that plaintiff's blood sugars had been well controlled and his cholesterol checks satisfactory, and he continued plaintiff on his current dose of Prednisone. (R. 491).

Plaintiff did "rather well" for the next month, until "getting out in a pea patch which resulted in some increased congestion for which he briefly boosted his Prednisone to 30 mg and then tapered very quickly back to his present dose." Dr. Prophet noted that "[h]e otherwise has done well with no major nocturnal symptoms" and that he was "stable overall." (R. 490). Plaintiff next saw Dr. Prophet just over a month later, after his hospitalization in July 2003 for cardiac catheterization and stent placement. Dr. Prophet noted that he was "stable as far as his asthma is concerned." (R. 489). In October 2003, two weeks after plaintiff's date last insured, Dr. Prophet wrote:

[Plaintiff] comes in getting along fairly well for this time of year. He has noted a little bit of increased wheezing in the last few weeks and increased his Prednisone to 10 mg a day for about a week and then has been on 5 mg a day for about a week, and this has resulted in good breathing. He is having no angina. Otherwise he has noted no unusual problems and states he has really done better over the last few months than he has in some time with the every other day Prednisone and also since his other stent was placed in July.

(R. 488). Dr. Prophet noted that since plaintiff was "fairly stable" he could "go back to every other day Prednisone after another week or two, and then if he is doing extremely well late in November he may want to try stopping the Prednisone." (Id.).

On January 6, 2004, plaintiff reported that he had done "fairly well over the last two or three months" and had stopped the Prednisone for about three weeks, until he had some trouble the week before Christmas and "boosted it back up[.]" He was then on 5 mg daily and was "breathing fairly well." Dr. Prophet noted that he was "having no angina or symptoms of heart failure and otherwise has felt well." Dr. Prophet wrote, "[He] is stable. I think he will need to maintain Prednisone at a very low dose indefinitely. Hopefully this can be done with an every other day regimen." (R. 487). In late March 2004, plaintiff reported problems for the preceding four or five days with increased wheezing, after a 24-hour episode of gastroenteritis. Dr. Prophet noted, "Also, there were some issues related to his mother and the stress of that also tends to cause him to have some wheezing. He has had no major sinus problems and states otherwise he has been doing quite well with 5 mg every other day Prednisone along with his other multiple medications. Recent laboratory regarding his cholesterol, etc., had been satisfactory and his blood sugars have done well." Dr. Prophet increased plaintiff's Prednisone to 60 mg for two days followed by a rapid taper back to the baseline dose. (R. 486).

Two months later, on May 28, 2004, Dr. Prophet wrote:

[He] comes in much improved after higher dose of Prednisone now maintaining at 5 mg daily. He has had no nocturnal wheezing or cough. He had minimal if any daytime symptoms. He notes no angina or symptoms of heart failure. Blood sugars are satisfactory. Some improvement may be due to the placement of his mother and disabled older brother in a nursing home and that transition seems to have gone quite well thus relieving a lot of mental and physical stress on [plaintiff].

(R. 485). Dr. Prophet noted that plaintiff was "doing quite well on his current medical regimen." (Id.). Dr. Prophet saw plaintiff six times over the next year and a half, during which plaintiff did well, reporting no angina or heart problems and good control of his blood sugar, with occasional "mild" or "little" flare-ups of his asthma. (R. 479-84). Plaintiff had an exacerbation of his asthma on December 12, 2005, three weeks after his cardiac defibrillator was implanted, precipitated by an upper respiratory infection. Dr. Prophet noted that the exacerbation "may or may not be able to be treated successfully as an outpatient" and that, "[g]iven his tenuous cardiac status, I feel it is safest to have him in as an observation patient." He admitted plaintiff to the hospital overnight "to receive a couple of doses of IV (intravenous) steroids and continued aerosols along with his other routine medicines," with a plan to discharge him the following day if he was stable. On December 13, 2005, plaintiff was discharged from the hospital. (Exhibit 6F, R. 361-382). Two months later, Dr. Prophet noted that he had "done well since [the brief hospitalization]" and was "stable." (R. 479).

Dr. Prophet saw plaintiff four times over the next eighteen months, during which plaintiff did well generally, except for several weeks of nasal stuffiness in early 2007 which led to worsening asthma symptoms, followed by a bout of gastroenteritis. Otherwise, plaintiff had occasional flare-ups of asthma requiring bursts of Prednisone but no "major interventions." (R. 475-78;see also R. 456, March 2006 visit to Dr. Morriss).

Plaintiff's Neuropathy

On May 31, 1999, plaintiff was referred to Dr. Steven Sykes of the Southeast Alabama Medical Center pain clinic for his complaints of "a two year history of a burning dysesthesialike pain of both feet[,]" in the soles of both feet and on the top and bottom of all of his toes. (R. 79-80). EMGs and nerve conduction studies in January 1999, a thoracic spine MRI, and a glucotrol study had all been negative. After obtaining a lumbar MRI, Dr. Sykes believed that plaintiff's symptoms were consistent with "a bilateral L5 radiculopathy secondary to neural foraminal canal stenosis." (R. 82, 106; see also R. 101). Dr. Sykes performed bilateral selective nerve root blocks, and bilateral L5-S1 facette joint injections on June 7, 1999 and started him on Celebrex. The treatments gave plaintiff no significant relief, leading Dr. Sykes to conclude that foraminal stenosis of L5, L5-S1 hypertrophy, and peripheral neuropathy were excluded as sources of plaintiff's pain. Dr. Sykes performed a diagnostic lumbar epidural steroid injection on June 30, 1999 to rule out the possibility of central canal stenosis. This also failed to give plaintiff any relief. Dr. Sykes concluded that plaintiff did not have central cord pathology or peripheral neuropathy, and thought that plaintiff's pain might be caused by a musculoskeletal etiology or, possibly, "a local peripheral neuropathy at the leve[l] of the ankle or below." He recommended that plaintiff be evaluated by a podiatrist. (R. 82-94).

Several months later, on January 20, 2000, plaintiff saw Dr. Sherrer at PrimeCare for a three-month check-up. He reported continued paresthesias of both feet which had not responded to medications prescribed by Dr. Sherrer and two neurologists. Dr. Sherrer referred plaintiff for orthopedic evaluation. (R. 580). On February 9, 2000, plaintiff was evaluated by Dr. David Alford at Southern Bone and Joint Specialists. Plaintiff told Dr. Alford that his feet were not actually painful, but "burning." He had a non-antalgic gait and could heel walk and toe walk without difficulty. His hind foot alignment, range of motion, strength and stability were normal, and he had +3 reflexes in both the knee and ankle. Compression at the tarsal tunnel increased plaintiff's burning sensation from a 5/10 to 6/10 bilaterally. Dr. Alford diagnosed peripheral neuropathy, and gave plaintiff some arch supports and some Zostrix cream to desensitize his feet. (R. 561-64). Plaintiff was a "no show" for follow-up visits scheduled with Dr. Alford for March 22, 2000 and April 3, 2000. (R. 561).

Plaintiff sought treatment from Dr. Sherrer's office fifteen times after the January 2000 visit, until July 2002. None of the other treatment notes reference foot problems. (R. 566-81).

The next treatment note of record regarding foot pain is dated December 8, 2003 — nearly four years after plaintiff was evaluated by Dr. Alford — when plaintiff sought treatment from Dr. Morriss complaining of "left lower extremity pain for 24 hours." He told Dr. Morriss that he awoke the previous day with the pain, and that it was a sharp, shooting type of pain when plaintiff stood, and lessened to a "sore" type of pain when he was seated. (R. 408). On March 10, 2004, Dr. Morriss noted that plaintiff "didn't get much help with the Elavil at 50 mg for his burning paresthesias of his feet. Dr. Morriss talked with plaintiff about increasing the Elavil dosage and, if that did not work, trying Neurontin. (R. 406). In July 2004, plaintiff reported that the increased dosages of Elavil had helped only a little. Dr. Morriss decided to try plaintiff on Mirapex before trying Neurontin. (R. 405). There is no further mention of foot paresthesias or neuropathy in plaintiff's medical record until May 24, 2005, when he complained of it to Dr. Morriss; on July 26, 2005, Dr. Morriss noted that he was "still [with] neuropathy. (R. 392-93).,

Plaintiff made no complaints of foot pain in his previous visits to Dr. Morriss on October 21, 2002, August 18, 2003 or November 21, 2003. (R. 410-11, 550-51).

Plaintiff sought treatment at Southern Clinic on October 22, 2004 for a flare-up of gouty arthritis in his left knee, which had resolved a week later (R. 394, 397, 403), a few times in November for cellulitis in his right lower leg (R. 398-404), and on February 18, 2005 for a routine check-up by Dr. Morriss (R. 394-95). The treatment notes for these office visits do not reference plaintiff's peripheral neuropathy or paresthesias. Between March 2006 and September 2007, Dr. Morriss saw plaintiff seven times for follow-up and lab work, and for evaluation and treatment of additional problems including — at various times — shoulder, neck, back and right flank pain; sinusitis; and conjunctivitis but the records do not mention foot pain, paresthesias or neuropathy. (Exhibit 14F, R. 444-56).

Plaintiff submitted records of eye examinations conducted by Dr. Danny Hartzog. Dr. Hartzog diagnosed allergic conjunctivitis and stable background diabetic retinopathy in both eyes in July 2002. (R. 585). In June 2003, he again noted early background diabetic retinopathy, with no treatment necessary. (R. 587). Dr. Hartzog saw plaintiff for check-ups, or complaints of red or itchy eyes in November 2003, October 2004, June 2005, and January 2006. (R. 589-595). In February 2006, he wrote to Dr. Morriss that plaintiff was myopic, but correctable to 20/25 in each eye, he had only background diabetic changes, no macular edema, and early nuclear cataracts, not reducing plaintiff's vision to the extent that surgery would be necessary in the foreseeable future. (R. 596). In May 2006, Dr. Hartzog completed a report of the January examination for the Disability Determination Services indicating that no treatment was required for plaintiff's minimal background diabetic retinopathy or his cataracts, and that no workplace precautions were indicated. (R. 419-20). In June 2006 treatment notes, he described plaintiff's diabetic retinopathy as mild and stable. (R. 597). In February 2007, he again indicated that no treatment was required for plaintiff's early, stable background diabetic retinopathy or his early cataracts. (R. 600). In August 2007, Dr. Hartzog noted mild macular edema, but stated that it was not clinically significant and that, as with plaintiff's background diabetic retinopathy and cataracts, no treatment was required. (R. 603).

DISCUSSION

The ALJ found that, prior to his date last insured, plaintiff retained the residual functional capacity to perform a range of light exertional work, with work requiring occasional climbing; frequent balancing, stooping, kneeling, crouching, and crawling; but no exposure to extreme cold and heat; and dangerous heights or machinery. (R. 16). The ALJ wrote that the RFC is supported by, inter alia: the findings of Dr. Morriss between August 2003 and March 2004; the assessments by Dr. Craven, plaintiff's cardiologist, in July 2000, April 2001, April 2002, and July 2003 and several months after the date last insured; the records of plaintiff's treating pulmonary specialist, Dr. Prophet, between December 2000 and January 2004; and the observations and findings of Dr. Sherrer of PrimeCare of Dothan between January 2000 and July 2002. (R. 14). The ALJ also cited the plaintiff's "wide range of activities of daily living," including "taking care of [his] own personal needs without assistance, shopping with assistance if he has a large grocery load, cooking, performing housework, visiting with medically ill mother and disabled brother daily, taking care of his dog and driving[,] and by working at onset and after onset at below SGA level[.]" (R. 14). The ALJ concluded that, "[t]hrough the date last insured, the [plaintiff's] past relevant work as a teacher did not require the performance of work-related activities precluded by the [plaintiff's RFC]." (R. 24). The ALJ stated, "I find that the [plaintiff] can return to his past relevant work as a teacher, not as he performed it, but as that work is performed in the national economy." (R. 15).

See R. 406-11.

See R. 418, 539-44.

See R. 487-503.

See R. 566-80.

In his discussion of plaintiff's past relevant work, the ALJ cited DOT # 091.221-010 as the listing for High School Teacher. (R. 15, 24). A review of the entire record indicates that this is a typographical error and that the ALJ intended to cite to DOT # 091.227-010. During the hearing, the ALJ questioned a Vocational Expert and asked whether she was able to match the plaintiff's work as a high school teacher with any occupation listed in the Dictionary of Occupational Titles. (R. 43). The Vocational Expert answered affirmatively and provided the ALJ with the listing for "teacher, secondary[,]" DOT 091.227-010. (R. 43-44). Plaintiff does not contend otherwise; he attaches this listing to his brief. (Doc. # 13-3).

Plaintiff contends that the ALJ's conclusion that he retains the RFC to perform light work exertionally is not supported by substantial evidence. Plaintiff notes that the record does not contain any opinions from any treating or examining physicians regarding plaintiff's work-related limitations, and that no state agency physician has reviewed the evidence. He contends that the ALJ erred in relying on the physical RFC assessment of the state agency disability examiner, Patricia Easley, because: (1) Easley's RFC assessment was a "current assessment" as of June 2006, not intended to relate back to plaintiff's date last insured, and which did not take into account all of the evidence submitted after the initial denial; and (2) Easley is not a doctor. Plaintiff further argues that the ALJ failed to consider the mental demands of his past work, and that the ALJ erred by failing to seek hearing testimony from a medical expert regarding whether plaintiff was disabled before his date last insured.

Plaintiff bears the burden of proving that he is disabled.Moore v. Barnhart, 405 F.3d 1208, 1211 (11th Cir. 2005) (citation omitted). However, he provided no medical source statement indicating that he is incapable of performing light work. InGreen v. Social Security Administration, 223 Fed. Appx. 915 (11th Cir. 2007) (unpublished opinion), the Eleventh Circuit reviewed a decision in which the ALJ had properly discredited a treating source's opinion regarding the claimant's capabilities, and then — without a physical capacities evaluation from any other medical source — determined that the claimant retained the residual functional capacity to perform light work. Finding that the ALJ's RFC determination was supported by substantial evidence, the Eleventh Circuit stated:

Green argues that without Dr. Bryant's opinion, there is nothing in the record for the ALJ to base his RFC conclusion that she can perform light work. As mentioned previously, the burden lies with the claimant to prove her disability . Moore, 405 F.3d at 1211. In the fourth step of that analysis, the ALJ determines the claimant's RFC and her ability to return to her past relevant work. Phillips v. Barnhart, 357 F.3d 1232, 1238 (11th Cir. 2004). In determining the claimant's RFC, the ALJ "must determine if the claimant is limited to a particular work level." Id. . . . Although a claimant may provide a statement containing a physician's opinion of her remaining capabilities, the ALJ will evaluate such a statement in light of the other evidence presented and the ultimate determination of disability is reserved for the ALJ. 20 C.F.R. §§ 404.1513, 404.1527, 404.1545.
* * * * *
Green argues that once the ALJ decided to discredit Dr. Bryant's evaluation, the record lacked substantial evidence to support a finding that she could perform light work. Dr. Bryant's evaluation, however, was the only evidence that Green produced, other than her own testimony, that refuted the conclusion that she could perform light work. Once the ALJ determined that no weight could be placed on Dr. Bryant's opinion of the Green's limitations, the only documentary evidence that remained was the office visit records from Dr. Bryant and Dr. Ross that indicated that she was managing her respiration problems well, that she had controlled her hypertension, and that her pain could be treated with over-the-counter medication. Thus, substantial evidence supports the ALJ's determination that Green could perform light work.
Green, 223 Fed. Appx. at 923-924. The Eleventh Circuit's analysis in Green, while not controlling, is persuasive, and the court finds plaintiff's argument (see plaintiff's brief at pp. 11-12) that the ALJ erred by making a residual functional capacity finding without an RFC assessment from a physician without merit. In formulating plaintiff's RFC in the present case, the ALJ — like the ALJ in Green — relied on the office treatment notes of plaintiff's medical providers. See R. 14 ("That residual functional capacity is supported, inter alia, by the findings of Dr. Morris[s] in Exhibit 9F at 18-25, Dr. Craven's assessment several months after the date last insured, Exhibit 10F at 5; Dr. Prophet's records in Exhibit 17F at 14-30; Dr. Craven's findings in 18F at 2, 4, 5, 6-7; and Dr. Sherrer's observations and findings in Exhibit 21F."). The medical record before the Commissioner, including the records first submitted to the Appeals Council, evidences no complaints of or treatment for foot pain or paresthesias between plaintiff's February 9, 2000 treatment by Dr. David Alford, when he was given arch supports and Zostrix cream, and December 8, 2003, when plaintiff complained to Dr. Morriss of left lower extremity pain persisting for 24 hours. Plaintiff has produced no evidence that he was experiencing symptoms of peripheral neuropathy during the period between his alleged onset date and his date last insured. (R. 408-11, 550-51, 56164). During this same period, plaintiff's cardiologist noted in annual check-ups in April 2001, April 2002, and April 2003 that plaintiff was stable and doing well from a cardiac perspective, and that he was experiencing no chest pain or tachycardia. Plaintiff did, thereafter, experience angina which resulted in a cardiac catheterization and stent placement in early July 2003. The stent placement apparently alleviated plaintiff's symptoms; at follow-up evaluations on July 31, 2003 and February 2004, Dr. Craven again described plaintiff as stable and without significant cardiac symptoms. The first report of chest discomfort after July 2003 — at least as evidenced in the record — occurred in October 2005, more than two years after plaintiff's date last insured. (R. 314-17, 337, 343-44, 363, 383-84, 394, 418, 430-39, 489, 539-44).

Plaintiff's persistent complaints during the relevant time period related to his asthma. Plaintiff experienced exacerbations of his asthma, some requiring treatment at the hospital and others requiring that he increase his dosage of Predisone, with the worst periods during the spring and fall of 2001 and 2002, and the spring of 2003. (See Exhibits 17F, 21F; pp. 13-18, supra). However, in assessing plaintiff's RFC, the ALJ relied, in part, on plaintiff's activities of daily living; the evidence permits a reasonable conclusion that, even when plaintiff was having more frequent problems with asthma, he remained fairly active. Additionally, while plaintiff asserts that he is disabled, in part, by fatigue (R. 41, 209-11), the record evidences only one period during which plaintiff complained to a physician of persistent fatigue, from early March through mid-April 2002. (R. 497-98, 567). Upon review of the evidence of record, the court concludes that the ALJ's RFC determination is supported by substantial evidence.

In his reply brief, plaintiff argues that his asthma "may well equal a listed impairment[,]" noting that the evidence "shows at least four hospital visits for asthma over a one year period[.]" (Plaintiff's reply brief, p. 6). Plaintiff cites the standard for medical equivalence, and quotes the Supreme Court's statement that, "[f]or a claimant to qualify for benefits by showing that his unlisted impairment, or combination of impairments, is `equivalent' to a listed impairment, he must present medical findings equal in severity to all the criteria for the one most similar listed impairment. Id. at n. 5 (emphasis added) (quotingSullivan v. Zebley, 493 U.S. 521, 531 (1990)). Plaintiff has not presented such evidence in this case. The listing for asthma, if implicated on the basis of severe asthma attacks, requires proof of "attacks . . . in spite of prescribed treatment and requiring physician intervention, occurring at least once every 2 months or at least six times a year." 20 C.F.R. 404, Subpart P, App. 1, ¶ 3.03(B). For purposes of the listing, asthma attacks are "prolonged symptomatic episodes lasting one or more days and requiring intensive treatment, such as intravenous bronchodilator or antibiotic administration or prolonged inhalational bronchodilator therapy in a hospital, emergency room or equivalent setting," and the listing requires medical evidence of the physical signs and, also, "spirometric results obtained between attacks that document the presence of baseline airflow obstruction." Id., ¶ 3.00(C). Plaintiff has not, however, produced hospital records of his admissions or ER treatment for asthma, or of spirometric results obtained between attacks, for the relevant time period before his date last insured. The brief references within the office treatment notes of plaintiff's doctors to earlier hospitalizations or ER visits for asthma are insufficient to establish that plaintiff met or equaled the listing for asthma; plaintiff has not presented evidence that his combination of impairments resulted in "medical findings equal in severity to all the criteria" of a listed impairment. Zebley, supra.

In June 2001, for instance, Dr. Prophet observed that Dr. Prophet indicated "[the plaintiff] had an up and down six months with several mild-to-moderate exacerbations of the asthma, at least one of which required an emergency room visit in April." (R. 502). At that time, plaintiff was driving to Barbour County and spending the night to help care for his mother, and returning home to work at his florist shop. (Id.). In December 2001, Dr. Prophet noted that plaintiff's asthma was aggravated, in part, by "the usual flurry of business activities" and dealing with his mother's health. (R. 501). In February 2002, Dr. Prophet observed that plaintiff's breathing may have been aggravated by "stress with Valentine's Day activities[.]" (R. 499).

The ALJ erred by relying on the opinion of the disability examiner, as she is not a medical source. See e.g., Nicholson v. Astrue, 2010 WL 4506997, *6 (W.D.N.C. Oct. 29, 2010) (finding that attributing weight to the opinion of a non-medical single decision maker ("SDM") is error and noting that "courts in the nine states where the SDM test model has been practiced have routinely rejected ALJs' reliance on RFCs created by SDMs"). In this case, the ALJ did not refer to the disability examiner as a medical source and, although he indicated that he gave her opinion "significant weight" (R. 16) and that he agreed with her assessment that plaintiff could perform light work (R. 15), he cited medical evidence sufficient to support his RFC determination (R. 14, 16). Additionally, as noted previously, plaintiff provided no medical source opinions regarding his limitations and, accordingly, the ALJ did not credit Easley's non-medical opinion over any medical opinion. Under these circumstances, the court concludes that the ALJ's error in considering Easley's opinion is harmless. While the court is puzzled by the ALJ's failure to include environmental limitations in addition to exposure to heat and cold in the RFC finding, plaintiff's past work as a secondary school teacher, as that work is performed in the national economy, does not include exposure to environmental conditions. (See DICOT 091.227-010, attached to plaintiff's brief). Thus, even if this failure is error, it is also harmless.

Plaintiff argues that the ALJ "erred in failing to consider the mental demands of [plaintiff's] past work." (Plaintiff's brief, pp. 12-14). Plaintiff rests this argument on a thin thread of evidence, relying on his hearing testimony that teaching is stressful (R. 34-35), and Dr. Prophet's notes that stress aggravated plaintiff's asthma and that "stress reduction would probably help" (R. 499, 501, 502). Dr. Prophet's suggestion that "stress reduction would probably help" plaintiff's asthma does not equate to a mental limitation from work involving stress. Dr. Prophet's reference to "stress" does not appear to relate entirely to mental stress — in May 2004, he observed that the placement of plaintiff's mother and older brother into a nursing home "reliev[ed] a lot of mental and physical stress on [plaintiff]." (R. 485). His earlier note reflected that plaintiff was "driving up [to Barbour County] frequently, spending the night, helping with her and plus doing his full time job here." (R. 502). Dr. Prophet's suggestion for stress reduction cannot fairly be read as an opinion that plaintiff cannot perform the mental demands of teaching or that he is limited to low-stress jobs and, accordingly, the ALJ did not err by failing to include a limitation to low-stress work in plaintiff's RFC. The court does not read SSR 82-62 to require an express finding or discussion regarding the mental demands of past work where the claimant's RFC includes no mental limitations. See SSR 82-62 ("Adequate documentation of past work includes factual information about those work demands which have a bearing on the medically established limitations.") (emphasis added).

Plaintiff then resided in Headland, Alabama. (See e.g., R. 61).

Dr. Prophet treated plaintiff for asthma for several years before plaintiff's heart attack and retirement from teaching. There is no indication in his treatment records for that period of time that the stress of plaintiff's work as a teacher aggravated plaintiff's asthma. (See Exhibit17F, R. 516-37). Rather, the only reference to stress was plaintiff's suggestion that his shortness of breath one night was due to stress associated with his floral business. (See R. 516) ("This [spell of shortness of breath], he thinks, was just due to stress as his bookkeeper walked out and quit on him that day. He had two weddings to do and was just under a lot of pressure.").

Plaintiff argues that SSR 82-62 "recognizes that individuals with cardiac impairments `may have performed stressful tasks,' and `[t]his may also require a decision as to whether the impairment is compatible with the performance of such work." (Plaintiff's brief, p. 13). However, plaintiff points to no medical source opinion or other medical evidence that — during the relevant time period, his cardiac and other impairments were incompatible with the mental demands of work as a teacher.

Finally, citing references applicable when a claimant's onset date must be inferred because of a slowly progressive condition that is non-traumatic in origin, plaintiff contends that the ALJ was required to call a medical expert to testify at the hearing regarding whether plaintiff was disabled before his date last insured. (Plaintiff's brief, pp. 14-15) (citations omitted). In the present case, however, plaintiff submitted records from his primary care physicians, his pulmonary specialist and his cardiologists for the period up to and following his date last insured. While plaintiff's cardiac condition and peripheral neuropathy may be slowly progressive conditions, the evidence offered by the plaintiff showed that plaintiff sought no treatment for peripheral neuropathy between his alleged onset date and his date last insured and that plaintiff's cardiologist noted that plaintiff was doing well from a cardiac perspective, with no significant cardiac symptoms, up until just before his heart catheterization and stent placement in early July 2003 and that, by July 31, 2003, plaintiff indicated to Dr. Craven that, overall, he was "very content with his current state of health" (R. 539). Thus, plaintiff responded favorably immediately following his stent placement. The evidence before the Commissioner permitted a conclusion, without the need for medical expert testimony, that plaintiff did not suffer from disabling limitations before his date last insured.

As noted above, plaintiff did not provide the records of his hospital admission in July 2003. Thus, there is little evidence of the duration or severity of his symptoms leading up to the admission.

Dr. Prophet's treatment notes, which continue through August 2007, generally reflect that the frequency and severity of plaintiff's asthma symptoms diminished over the four years following his date last insured. (See Exhibit 17F, R. 475-89).

CONCLUSION

For the foregoing reasons and upon review of the record as a whole, the court concludes that the decision of the Commissioner is supported by substantial evidence and proper application of the law. Accordingly, the decision is due to be affirmed. A separate judgement will be entered.

Done, this 8th day of December, 2010.